The Use of Sensitive Chemical Antibodies for Diagnosis: Detection of Low Levels of Epcam in Breast Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Use of Sensitive Chemical Antibodies for Diagnosis: Detection of Low Levels of Epcam in Breast Cancer
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 2, Pages e57613
Publisher
Public Library of Science (PLoS)
Online
2013-02-28
DOI
10.1371/journal.pone.0057613
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aptamers as Remarkable Diagnostic and Therapeutic Agents in Cancer Treatment
- (2012) Henri-Pierre Lassalle et al. CURRENT DRUG METABOLISM
- High Interstitial Fluid Pressure Is Associated with Low Tumour Penetration of Diagnostic Monoclonal Antibodies Applied for Molecular Imaging Purposes
- (2012) Markus Heine et al. PLoS One
- Why is it crucial to reintegrate pathology into cancer research?
- (2011) Jaime Rodriguez-Canales et al. BIOESSAYS
- Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies
- (2011) Sarah Shigdar et al. BRITISH JOURNAL OF HAEMATOLOGY
- RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
- (2011) Sarah Shigdar et al. CANCER SCIENCE
- Epithelial cell adhesion molecule expression (CD326) in cancer: A short review
- (2011) Carlo Patriarca et al. CANCER TREATMENT REVIEWS
- EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis
- (2011) Gilbert Spizzo et al. JOURNAL OF CLINICAL PATHOLOGY
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- Where Are All the Aptamers?
- (2010) Geoffrey S. Baird AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Antibody validation
- (2010) Jennifer Bordeaux et al. BIOTECHNIQUES
- Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies
- (2010) Dalibor Antolovic et al. BMC BIOTECHNOLOGY
- EpCAM in carcinogenesis: the good, the bad or the ugly
- (2010) B. T. F. van der Gun et al. CARCINOGENESIS
- EpCAM As a Target in Cancer Therapy
- (2010) Olivier Gires et al. JOURNAL OF CLINICAL ONCOLOGY
- Using oligonucleotide aptamer probes for immunostaining of formalin-fixed and paraffin-embedded tissues
- (2010) Zihua Zeng et al. MODERN PATHOLOGY
- Quantitating Antibody Uptake In Vivo: Conditional Dependence on Antigen Expression Levels
- (2010) Greg M. Thurber et al. MOLECULAR IMAGING AND BIOLOGY
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases
- (2009) Ashley Cimino et al. BREAST CANCER RESEARCH AND TREATMENT
- Ligand-based targeted therapy for cancer tissue
- (2009) Manasi Das et al. Expert Opinion on Drug Delivery
- Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer
- (2008) M. Schmidt et al. CLINICAL CANCER RESEARCH
- Antisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible?
- (2008) E RAYBURN et al. DRUG DISCOVERY TODAY
- Is my antibody-staining specific? How to deal with pitfalls of immunohistochemistry
- (2008) Jean-Marc Fritschy EUROPEAN JOURNAL OF NEUROSCIENCE
- Current issues in ER and HER2 testing by IHC in breast cancer
- (2008) Allen M Gown MODERN PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now